This contract opportunity involves the establishment of non-exclusive discount contracts for the pharmaceutical products Naproxen and Esomeprazole, in accordance with German social law. The contracts will be valid from February 1, 2026, to January 31, 2028, and suppliers can enter into contracts at
529 days left to bid. Opened 6 months ago, deadline 30 Nov 2027.
The AOK Rheinland-Pfalz/Saarland - The Health Fund is issuing a framework agreement for "Seating Furniture" consisting of a total of 4 lots. This specific tender is for Lot 3, which involves establishing a framework agreement for the purchase, delivery to the designated location, assembly/installati
The Open-House procedure for pharmaceutical discount contracts involving the active ingredient Pazopanib (ATC L01EX03), identified by the code "484904-2024", will be terminated effective January 31, 2026. Existing contracts will be canceled at that time, and no new contracts can be concluded under t
This contract opportunity involves the establishment of non-exclusive discount contracts for the medications Olmesartan and Hydrochlorothiazide. These contracts will be in effect from February 1, 2026, to January 31, 2028, and can be signed at any time during this period (open-house model). Please n
This contract opportunity involves the establishment of non-exclusive discount contracts for the medication Glatiramer Acetate, specifically for pre-filled syringes. The contracts will be in effect from February 1, 2026, to January 31, 2028, with the option for suppliers to enter into contracts at a
Adoption Counts is accepting applications for a therapy services framework that reopens every 4 months to ensure market competition and access to innovative support services.
Betsi Cadwaladr University Health Board is procuring pathology testing services for HFE gene analysis and extraction.
Powys Teaching Health Board seeks an experienced dental provider to deliver NHS General Dental Services in Llandrindod Wells.
UK Atomic Energy Authority seeks suppliers of Infrared Thermography Cameras for MAST-U diagnostic equipment; responses due 3 June 2026.